基于细胞外囊泡的液体活检生物标志物及其在精密免疫瘤学的应用
Karama Asleh1, Valerie Dery2, Catherine Taylor3
1Atlantic Cancer Research Institute, Moncton, New Brunswick, Canada. karamaa@canceratl.ca.
Biomarker research
|November 18, 2023
概括
细胞外囊泡 (EVs) 为精密瘤学提供最小侵入性的生物标志物. 这些囊泡促进细胞间通信,有助于监测治疗反应和预测免疫治疗的耐药性.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 免疫治疗是一种免疫疗法.
背景情况:
- 精密瘤学面临的挑战是治疗耐药性,特别是免疫疗法,通常是由于瘤微环境的改变.
- 目前的基于组织的生物标志物具有侵入性,缺乏实时疾病监测能力.
- 微创生物标志物对于预测治疗反应,监测疾病进展和检测复发至关重要.
研究的目的:
- 审查细胞外囊泡 (EVs) 在精确瘤学生物标志物研究中的新兴作用.
- 讨论电动汽车隔离和分析技术的进展.
- 突出EVs作为免疫治疗反应和临床应用的预测生物标志物的潜力.
主要方法:
- 关于癌症研究中的细胞外囊泡 (EVs) 的当前文献的综述.
- 讨论创新的EV捕获技术 (微流体,磁珠,阿普塔米).
- 探索用于EV分析和生物标志物发现的高吞吐量多态和人工智能.
主要成果:
- EVs调解细胞间通信,影响瘤微环境,并影响药物反应.
- 电动汽车作为生物标志物的来源,用于实时监测疾病和治疗.
- 对肺癌和黑色素瘤的研究表明,EVs作为免疫治疗的预测生物标志物具有前景.
结论:
- 细胞外囊泡 (EVs) 是精确免疫瘤学的宝贵工具,可以实时了解细胞通信.
- 先进的隔离和分析技术与人工智能相结合,增强了基于EV的生物标志物发现.
- 电动汽车具有克服治疗耐药性和改善癌症治疗患者治疗结果的巨大潜力.
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530